• 1. Department of Cardiology, Chengdu Third People's Hospital, Chengdu, Sichuan, 610031, China;
  • 2. ;
ZengXuefeng, Email: 470422671@qq.com
Export PDF Favorites Scan Get Citation

Objective To explore the prevalence of depression and anxiety of chronic obstructive pulmonary disease complicated coronary artery disease before and after percutaneous intracoronary arterial stenting. Methods A total of 114 chronic obstructive pulmonary disease complicated coronary artery disease patients were enrolled in this study and were measured with the Hospital Anxiety and Depression Scale before and after percutaneous intracoronary arterial stenting. Results A total of 71 patients (62.3%) had depression symptom and 68 patients (59.6%) had anxiety symptom before percutaneous intracoronary arterial stenting. There were 46 patients (40.4%) had significant depression symptom and 40 patients (35.1%) had significant anxiety symptom before percutaneous intracoronary arterial stenting. A total of 85 patients (74.6%) had depression symptom and 83 patients (72.8%) had anxiety symptom after percutaneous intracoronary arterial stenting. There were 60 patients (52.6%) had significant depression symptom and 48 patients (42.1%) had significant anxiety symptom after percutaneous intracoronary arterial stenting. There was significant difference in prevalence rate of depression and anxiety before and after percutaneous intracoronary arterial stenting (P < 0.05). Conclusions The patients with chronic obstructive pulmonary disease complicated coronary artery disease show higher prevalence of depression and anxiety. The prevalence of depression and anxiety increases significantly after percutaneous intracoronary arterial stenting.

Citation: DaiMei, ZengXuefeng, WangChao, HuJianying, JiangHui, WangYinli. Analysis of Depression and Anxiety in Patients with Chronic Obstructive Pulmonary Disease Complicated Coronary Artery Disease before and after Percutaneous Intracoronary Arterial Stenting. Chinese Journal of Respiratory and Critical Care Medicine, 2015, 14(5): 439-441. doi: 10.7507/1671-6205.2015109 Copy

  • Previous Article

    Lung Capacity and Diffusing Capacity in Patients with Chronic Obstructive Pulmonary Disease at Different Stages
  • Next Article

    Intranasal Administration of Interleukin-27 Alleviates Airway Allergic Inflammation of Ovalbumin-induced Mouse Asthma Model via STAT1 Signal Pathway